Medical Robotics Global Market Report 2024

The medical robotics market size has grown rapidly in recent years. It will grow from $12.76 billion in 2023 to $14.9 billion in 2024 at a compound annual growth rate (CAGR) of 16.8%. The growth during the historical period can be attributed to a rising demand for precision and accuracy in medical procedures, a growing acceptance of minimally invasive surgery, the increase in chronic diseases, investments in research and development, and the expanding range of applications for these technologies in healthcare.

The medical robotics market size is expected to see rapid growth in the next few years. It will grow to $29.22 billion in 2028 at a compound annual growth rate (CAGR) of 18.3%. The projected growth in the forecast period is due to several factors such as the increasing consumer demand for enhanced healthcare services, supportive regulatory frameworks and standards, improved accessibility and affordability in healthcare, the rising demand for remote surgery and telepresence, and the integration of AI and machine learning technologies. Key trends expected during this period encompass the development of patient-centric robotics, advancements in surgical techniques, a surge in minimally invasive surgeries, an expanded role in rehabilitation through robotics, and a growing demand for telepresence and remote surgical procedures.

The increasing preference for minimally invasive surgery (MIS) is playing a significant role in driving the growth of the medical robotics market. Minimally invasive surgery encompasses a range of techniques, including the use of medical robots, to perform surgical procedures with reduced trauma to the body compared to traditional open surgery. This approach is gaining popularity among patients due to its associated benefits, such as reduced postoperative pain, lower risk of complications, shorter hospital stays, and faster recovery times. For example, research conducted by Johns Hopkins investigators and published in JAMA Surgery has shown that American hospitals could prevent thousands of post-surgical complications and save between $280 million and $340 million annually by opting for more minimally invasive procedures for routine operations involving the appendix, colon, and lungs, as compared to traditional open surgery. Additionally, data from the American Society of Plastic Surgeons indicates that in September 2023, there were 26.2 million minimally invasive and surgical treatments performed in the US. As the demand for minimally invasive surgical techniques continues to rise, driven by patient preferences and the associated clinical and economic benefits, the medical robotics market is expected to experience significant growth. This trend underscores the increasing role of medical robotics in enabling and enhancing minimally invasive surgical procedures, thereby driving advancements in healthcare delivery and patient outcomes.

The increasing prevalence of chronic diseases, particularly cardiovascular diseases (CVDs), is expected to drive the growth of the medical robotics market in the coming years. CVDs encompass a group of conditions that affect the circulatory system, including the heart and blood vessels. Medical robots are increasingly used in the treatment of CVDs to perform minimally invasive surgeries, such as robot-assisted cardiac procedures, which can improve surgical precision and reduce patient trauma. For example, data from the Australian Institute of Health and Welfare indicates a concerning rise in doctor-certified fatalities due to coronary heart disease (CHD) in recent years. The number of fatalities increased from 13,700 in 2020 to 14,900 in 2022, based on preliminary mortality figures. This trend underscores the growing impact of chronic diseases such as CVDs on global health and the need for advanced medical technologies such as robotics to address these challenges. Therefore, the increasing prevalence of chronic diseases, particularly cardiovascular diseases, is a significant driver behind the growth of the medical robotics market, as these advanced technologies play a crucial role in improving treatment outcomes and patient care in the face of rising disease burdens.

Strategic collaboration between companies is increasingly becoming a prominent trend in the medical robotics market. Companies operating in this industry are engaging in various collaborations to drive the development of new technologies and products. For example, in February 2022, Novanta, a US-based advanced photonics company, announced a strategic collaboration with MassRobotics, a US-based robotics and AI company, aimed at advancing innovations in medical and surgical robotics. As part of this collaboration, Novanta's business units, Celera Motion and ATI Industrial Automation, will work closely with MassRobotics to develop advanced innovations in medical and surgical robotics, with a focus on enhancing robotic productivity and efficiency.

Major companies in the medical robotics market are focusing on innovative products, particularly robotic platforms, to better serve their existing consumers. A robotic solution refers to a comprehensive application or solution that utilizes robotic technology to address specific tasks, issues, or demands. For example, in May 2023, Robocath, a France-based company specializing in medical robotic solutions for heart-related diseases, introduced an innovative robotic platform called the R-One+. The R-One+ robotic system enables interventional cardiologists to perform coronary angioplasties by controlling the devices using a centralized command unit in the cathlab or control room. This approach offers two key advantages: it protects the cardiologist and medical staff from radiation-related risks, and it streamlines and secures the PCI (Percutaneous Coronary Intervention) process. Cardiologists can now perform more precise hand movements in more ergonomic working environments, ultimately benefiting patients. This focus on advanced robotic platforms reflects the industry's commitment to enhancing medical procedures and outcomes through robotic technology.

In April 2023, CardioVentures Inc., a UK-based medical device company, merged with AVRA Medical Robotics Inc. for an undisclosed sum. Following the merger, AVRA Medical Robotics aims to allocate a significant portion of its resources to expanding and reinforcing the operations of SSI-India, which will become the company's indirect majority-owned subsidiary. As part of this transition, the company's name has been changed to SS Innovations International, Inc. AVRA Medical Robotics Inc. is known for developing medical robot software and artificial intelligence.

Major companies operating in the medical robotics market report are Johnson & Johnson, Medtronic plc, Siemens Healthineers AG, Stryker Corporation, GE Healthcare, Philips Healthcare, Boston Scientific Corporation, Intuitive Surgical, Smith & Nephew plc, BD Rowa, KUKA Roboter GmbH, Varian Medical Systems, Kirby, Omnicell, Auris Health Inc., iRobot Corporation, Globus Medical, Hansen Medical, Renishaw plc, Accuray Inc., Kinova Robotics, Hocoma AG, Titan Medical Inc., Ekso Bionics, TransEnterix Inc., ReWalk Robotics, Mazor Robotics, Houston Medical Robotics, ARxIUM, Medrobotics Corporation.

North America will be the largest region in the medical robotics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical robotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the medical robotics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

In the field of medical robotics, the main product types are surgical robotics systems, rehabilitation robotics systems, and non-invasive radiosurgery systems. Surgical robotics systems utilize computer technologies and robots to assist in performing medical procedures such as laparoscopy, neurosurgery, cardiology, orthopedic surgery, and pharmacy applications. These systems are commonly used in hospitals, clinics, specialty centers, and rehabilitation centers.

The medical robotics market research report is one of a series of new reports that provides medical robotics market statistics, including the medical robotics industry global market size, regional shares, competitors with a medical robotics market share, detailed medical robotics market segments, market trends and opportunities, and any further data you may need to thrive in the medical robotics industry. This medical robotics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

The medical robotics market consists of sales of surgical robots / robot-assisted surgery machine, rehabilitation robots, laboratory robots, hospital robots, social robots. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.